Literature DB >> 22055333

Cytokine changes in the pathophysiology of poststroke depression.

Jian-An Su1, Shih-Yong Chou, Ching-Shu Tsai, Tai-Hsin Hung.   

Abstract

OBJECTIVE: Poststroke depression (PSD) is a frequent psychiatric sequela after stroke, and its influence is detrimental. However, the etiology of PSD is still not clear. Although many studies have indicated that immune dysregulation plays an important role in the pathophysiology of depression, it is still unknown if PSD involves the same mechanism. Thus, the current study objectives were to evaluate whether there were cytokine changes when patients with ischemic stroke suffered from PSD.
METHOD: We included ischemic stroke patients without depression when the stroke occurred and followed them for 1 year. The Hamilton Depression Rating Scale score and cytokines were assessed at baseline and at the 1st, 3rd, 6th, 9th and 12th months after stroke.
RESULTS: One hundred four patients with ischemic stroke participated and completed the study, and 12 suffered from PSD during the 1-year study period. There were significant increases in the cytokines interleukin-6 (IL-6), interleukin-10 (IL-10), tumor necrosis factor α (TNF-α) and interferon-γ, and the ratios of IL-6/IL-10 and TNF-α/IL-10 were also elevated. Interleukin-1β was too low to show any difference.
CONCLUSION: Our study suggested that immune imbalance plays a possible role in the pathophysiology of PSD and that IL-6 and TNF-α are key cytokines. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22055333     DOI: 10.1016/j.genhosppsych.2011.09.020

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  21 in total

1.  Association between inflammatory cytokines and the risk of post-stroke depression, and the effect of depression on outcomes of patients with ischemic stroke in a 2-year prospective study.

Authors:  Jian-Tong Jiao; Chao Cheng; Ying-Jun Ma; Jin Huang; Min-Chao Dai; Chen Jiang; Cheng Wang; Jun-Fei Shao
Journal:  Exp Ther Med       Date:  2016-06-30       Impact factor: 2.447

Review 2.  Exosomes in Acquired Neurological Disorders: New Insights into Pathophysiology and Treatment.

Authors:  Nicole Osier; Vida Motamedi; Katie Edwards; Ava Puccio; Ramon Diaz-Arrastia; Kimbra Kenney; Jessica Gill
Journal:  Mol Neurobiol       Date:  2018-04-16       Impact factor: 5.590

Review 3.  Natural Products for the Treatment of Post-stroke Depression.

Authors:  Chaoyou Fang; Zeyu Zhang; Houshi Xu; Yibo Liu; Xiaoyu Wang; Ling Yuan; Yuanzhi Xu; Zhengyang Zhu; Anke Zhang; Anwen Shao; Meiqing Lou
Journal:  Front Pharmacol       Date:  2022-05-30       Impact factor: 5.988

Review 4.  Immune responses to stroke: mechanisms, modulation, and therapeutic potential.

Authors:  Costantino Iadecola; Marion S Buckwalter; Josef Anrather
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

5.  Strain differences in fatigue and depression after experimental stroke.

Authors:  Allison Kunze; Dannielle Zierath; Olga Drogomiretskiy; Kyra Becker
Journal:  Transl Stroke Res       Date:  2014-06-12       Impact factor: 6.829

6.  Effect and mechanism of fluoxetine on electrophysiology in vivo in a rat model of postmyocardial infarction depression.

Authors:  Jinjun Liang; Xiaoran Yuan; Shaobo Shi; Fang Wang; Yingying Chen; Chuan Qu; Jingjing Chen; Dan Hu; Bo Yang
Journal:  Drug Des Devel Ther       Date:  2015-02-10       Impact factor: 4.162

7.  The Association Between Systemic Inflammatory Markers and Post-Stroke Depression: A Prospective Stroke Cohort.

Authors:  Jingjie Hu; Liuyuan Wang; Kaili Fan; Wenwei Ren; Qiongzhang Wang; Yiting Ruan; Chengxiang Yuan; Guiqian Huang; Jincai He
Journal:  Clin Interv Aging       Date:  2021-06-25       Impact factor: 4.458

8.  Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses.

Authors:  Marie-Claude Audet; Hymie Anisman
Journal:  Front Cell Neurosci       Date:  2013-05-10       Impact factor: 5.505

9.  Poststroke neuropsychiatric symptoms: relationships with IL-17 and oxidative stress.

Authors:  W Swardfager; N Herrmann; A C Andreazza; R H Swartz; M M Khan; S E Black; K L Lanctôt
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

10.  Kynurenine and depressive symptoms in a poststroke population.

Authors:  Kira Bensimon; Nathan Herrmann; Walter Swardfager; Hao Yi; Sandra E Black; Fu-Qiang Gao; Abraham Snaiderman; Krista L Lanctôt
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-22       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.